SURG
SurgePays, Inc.
NASDAQ · Technology · Software - Application · US
$0.12
−5.26%Year over year
Reported trailing growth
- Revenue
- +83.9%
- EBITDA
- +25.3%
- EBIT
- +23.5%
- EPS
- +37.9%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +1.6%
- EBITDA
- +110.3%
- EPS
- +96.7%
Three-year CAGR
- Revenue
- -22.3%
- EBITDA
- +20.1%
- EBIT
- +18.3%
- Net income
- +21.1%
- EPS
- +24.7%
- Free cash flow
- +2.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026